Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04541225
Title Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio, Inc.
Indications

high grade glioma

Therapies

NUV-422

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates Tucson Arizona 85711 United States Details
Miami Cancer Institute Miami Florida 33176 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
Prisma Health Cancer Institute Greenville South Carolina 29605 United States Details
Texas Oncology P.A. Austin Austin Texas 78705 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Oncology Tyler Texas 75702 United States Details
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field